Document is current
Any future updates will be listed below
-
Authors
Castelli, Marta
Micò, Maria Caterina
Grassi, Anna
Algarotti, Alessandra
Lussana, Federico https://orcid.org/0000-0002-6510-8616
Finazzi, Maria Chiara https://orcid.org/0000-0002-1857-5836
Rambaldi, Benedetta
Pavoni, Chiara
Rizzuto, Giuliana
Tebaldi, Paola
Vendemini, Francesca
Verna, Marta
Bonanomi, Sonia
Biondi, Andrea
Balduzzi, Adriana https://orcid.org/0000-0002-5879-0610
Rambaldi, Alessandro https://orcid.org/0000-0002-3739-7502
Gotti, Giacomo https://orcid.org/0000-0001-5024-7894
- License Information
-
More Information
Article History
Received: 27 February 2024
Revised: 29 April 2024
Accepted: 30 April 2024
First Online: 21 May 2024
Competing interests
: MCM: Novartis: Honoraria. AB: Neovii: Speakers Bureau; Medac: Speakers Bureau; Agmen: Speakers Bureau; Novartis: Speakers Bureau. AB: Colmmune: Membership on an entity’s Board of Directors or advisory committees, Research Funding; Agmen: Speakers Bureau; BMS: Membership on an entity’s Board of Directors or advisory committees; Novartis: Speakers Bureau; Galapagos: Membership on an entity’s Board of Directors or advisory committees. FL: Amgen: Speakers Bureau; Pfizer: Membership on an entity’s Board of Directors or advisory committees and Speakers Bureau; Incyte: Speakers Bureau; Bristol Myers Squibb: Membership on an entity’s Board of Directors or advisory committees and Speakers Bureau; AbbVie: Membership on an entity’s Board of Directors or advisory committees; Clinigen Membership on an entity’s Board of Directors or advisory committees. AR: Astellas: Honoraria; Pfizer: Honoraria; Agmen: Honoraria; Omeros: Honoraria; Novartis: Honoraria; Kite-Gilead: Honoraria; Jazz: Honoraria; Celgene-BMS: Honoraria; Janssen: Honoraria; Roche: Honoraria; Incyte: Honoraria; ABBVIE: Honoraria. GG: Omeros: Congress Support.
